Foresite Capital Opportunity Fund V, L.P.
Insider CIK 1792205 · THRX 10% owner · KNTE 10% owner · GMTX 10% owner · PRDS 10% owner · ALMS 10% owner · EIKN 10% owner · LTGO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | $0 | 2,203,800 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 296,880 | — | $0 | 3,414,544 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 195,776 | — | — | 2,203,800 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | P Buy | 2026-08-10 | 2026-08-10 | 140,000 | $18.00 | $2.52M | 2,008,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 742,201 | — | $0 | 1,868,024 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,125,823 | — | $0 | 1,125,823 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 445,320 | — | $0 | 3,562,984 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,117,664 | — | $0 | 3,117,664 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,123,337 | — | $0 | 1,123,337 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 680,486 | — | $0 | 680,486 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,123,337 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | J Other | 2026-04-01 | 2026-04-03 | 1,176,470 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 2,502,252 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 10,000,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 5,204,684 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 2,602,342 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 3,422,051 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 1,711,025 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 284,392 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 501,219 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 6,878 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 12,123 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 3,048,192 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 335,521 | — | $0 | 1,676,399 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 408,725 | — | $0 | 408,725 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 38,133 | — | $0 | 425,852 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 922 | — | $0 | 387,719 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 386,797 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 348,942 | — | $0 | 348,942 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 458,855 | — | $0 | 1,263,428 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 67,207 | — | $0 | 804,573 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 1,626 | — | $0 | 737,366 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 735,740 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 697,885 | — | $0 | 697,885 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 229,428 | — | $0 | 1,943,682 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 1,714,254 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 55,555 | $18.00 | $1000.0K | 1,318,983 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 1,340,878 | — | $0 | 1,340,878 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-01-08 | 2026-01-12 | 294,117 | $17.00 | $5.00M | 2,908,332 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-01-08 | 2026-01-12 | 117,647 | $17.00 | $2.00M | 5,702,536 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-21 | 2025-11-25 | 72,212 | $7.38 | $532.9K | 2,614,215 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-19 | 2025-11-19 | 190,500 | $6.56 | $1.25M | 2,542,003 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-18 | 2025-11-19 | 117,374 | $6.19 | $726.5K | 2,351,503 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-17 | 2025-11-19 | 150,000 | $5.59 | $838.5K | 2,234,129 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-17 | 2025-11-19 | 50,000 | $5.60 | $280.0K | 2,084,129 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-06 | 2025-05-06 | 20,000 | $4.34 | $86.8K | 4,247,670 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-02 | 2025-05-06 | 25,000 | $4.62 | $115.5K | 4,227,670 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,944,577 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 194,459 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,122,994 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 967,567 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 622,344 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,022,398 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 1,703,998 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 481,283 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,122,994 | — | $0 | 3,067,571 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 622,344 | — | $0 | 4,249,991 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,022,398 | — | $0 | 5,272,389 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2024-07-01 | 2024-07-03 | 312,500 | $16.00 | $5.00M | 5,584,889 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 194,459 | — | $0 | 194,459 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 481,283 | — | $0 | 481,283 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 1,041,359 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 1,352,531 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 2,034,129 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 967,567 | — | $0 | 967,567 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 1,278,739 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 681,598 | — | $0 | 1,960,337 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 311,172 | — | $0 | 311,172 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,703,998 | — | $0 | 2,015,170 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2024-07-01 | 2024-07-03 | 2,187,500 | $16.00 | $35.00M | 4,202,670 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 1,944,577 | — | $0 | 1,944,577 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-03 | 560,076 | — | $0 | 3,627,647 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 9,671,643 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 520,711 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 3,525,957 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 37,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 37,500 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer deriv | 2023-08-31 | 2023-08-31 | 75,000 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | J Other | 2023-08-31 | 2023-08-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | D To issuer | 2023-08-31 | 2023-08-31 | 16,813,146 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 523,450 | $2.97 | $1.55M | 4,108,796 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2023-07-17 | 2023-07-19 | 176,550 | $2.97 | $524.4K | 1,385,825 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 229,044 | $2.80 | $641.3K | 520,711 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 1,550,956 | $2.80 | $4.34M | 3,525,957 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2023-04-05 | 2023-04-06 | 773,952 | $1.50 | $1.16M | 8,773,134 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | J Other | 2023-02-17 | 2023-02-22 | 1,100,000 | — | $0 | 1,975,001 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-29 | 2023-01-03 | 250,000 | $5.00 | $1.25M | 1,209,275 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-12-29 | 2023-01-03 | 250,000 | $5.00 | $1.25M | 3,585,346 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2021-12-23 | 2022-06-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-28 | 4,873,750 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award deriv | 2021-12-23 | 2021-12-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion deriv | 2021-12-23 | 2021-12-30 | 4,941,250 | — | $0 | 0 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-28 | 4,873,750 | — | $0 | 4,873,750 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award | 2021-12-23 | 2021-12-28 | 1,000,000 | $10.00 | $10.00M | 1,000,000 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | A Award | 2021-12-23 | 2021-12-28 | 7,759,072 | — | $0 | 7,759,072 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | C Conversion | 2021-12-23 | 2021-12-30 | 4,941,250 | — | $0 | 4,941,250 | SEC↗ |
| PRDS PARDES BIOSCIENCES, INC. | P Buy | 2021-12-22 | 2021-12-23 | 325,000 | $10.00 | $3.25M | 325,000 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | C Conversion deriv | 2021-02-05 | 2021-02-09 | 2,928,750 | — | $0 | 0 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | C Conversion | 2021-02-05 | 2021-02-09 | 2,928,750 | — | $0 | 2,928,750 | SEC↗ |
| GMTX Gemini Therapeutics, Inc. | A Award | 2021-02-05 | 2021-02-09 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 48,376 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 145,128 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 157,222 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 18,641 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 55,922 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,666,002 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 99,488 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 298,465 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 6,347,893 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,171,643 | — | $0 | 9,671,643 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 166,667 | — | $0 | 291,667 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 500,001 | — | $0 | 875,001 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 125,000 | $20.00 | $2.50M | 125,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 500,000 | $20.00 | $10.00M | 500,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 375,000 | $20.00 | $7.50M | 375,000 | SEC↗ |